Vistagen Therapeutics, Inc. appointed Dr. Angel S. Angelov as Chief Medical Officer effective May 18, 2026, with an annual salary of $425,000, a $50,000 signing bonus, and stock options for 150,000 shares. This event is significant for the company and carries a positive sentiment.